Articles

• Impact of multiple sclerosis relapses on progression diminishes with time

  H. Tremlett, M. Yousefi, V. Devonshire, P. Rieckmann, Y. Zhao

  • Abstract
  • Full Text
  • Full Text (PDF)
• Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis

  J. Bellmann-Strobl, J. Wuerfel, O. Aktas, J. Dörr, K. D. Wernecke, F. Zipp, F. Paul

  • Abstract
  • Full Text
  • Full Text (PDF)
• Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis

  K. Yanagawa, I. Kawachi, Y. Toyoshima, A. Yokoseki, M. Arakawa, A. Hasegawa, T. Ito, N. Kojima, R. Koike, K. Tanaka, T. Kosaka, C. -F. Tan, A. Kakita, K. Okamoto, M. Tsujita, K. Sakimura, H. Takahashi, M. Nishizawa

  • Abstract
  • Full Text
  • Full Text (PDF)

  CME Course
• Rapid appearance of new cerebral microbleeds after acute ischemic stroke

  S. -B. Jeon, S. U. Kwon, A. -H. Cho, S. -C. Yun, J. S. Kim, D. -W. Kang

  • Abstract
  • Full Text
  • Full Text (PDF)

  CME Course
• Impaired kidney function and cerebral microbleeds in patients with acute ischemic stroke

  A. -H. Cho, S. B. Lee, S. J. Han, Y. -M. Shon, D. -W. Yang, B. S. Kim

  • Abstract
  • Full Text
  • Full Text (PDF)
• Cortical event-related potentials in preclinical familial Alzheimer disease

  E. J. Golob, J. M. Ringman, R. Irimajiri, S. Bright, B. Schaffer, L. D. Medina, A. Starr

  • Abstract
  • Full Text
  • Full Text (PDF)
• Determinants of survival in behavioral variant frontotemporal dementia

  B. Garcin, P. Lillo, M. Hornberger, O. Piguet, K. Dawson, P. J. Nestor, J. R. Hodges

  • Abstract
  • Full Text
  • Full Text (PDF)
• Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

  C. W. Christine, P. A. Starr, P. S. Larson, J. L. Eberling, W. J. Jagust, R. A. Hawkins, H. F. VanBrocklin, J. F. Wright, K. S. Bankiewicz, M. J. Aminoff

  • Abstract
  • Full Text
  • Full Text (PDF)
• History of falls in Parkinson disease is associated with reduced cholinergic activity

  N. I. Bohnen, M. L.T.M. Müller, R. A. Koeppe, S. A. Studenski, M. A. Kilbourn, K. A. Frey, R. L. Albin

  • Abstract
  • Full Text
  • Full Text (PDF)
• Bevacizumab for recurrent ependymoma

  R. M. Green, T. F. Cloughesy, R. Stupp, L. M. DeAngelis, E. A. Woyshner, D. E. Ney, A. B. Lassman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Lower serum lipid levels are related to respiratory impairment in patients with ALS

  A. Chiò, A. Calvo, A. Ilardi, E. Cavallo, C. Moglia, R. Mutani, A. Palmo, R. Galletti, K. Marinou, L. Papetti, G. Mora

  • Abstract
  • Full Text
  • Full Text (PDF)
• Study of 962 patients indicates progressive muscular atrophy is a form of ALS

  W. -K. Kim, X. Liu, J. Sandner, M. Pasmantier, J. Andrews, L. P. Rowland, H. Mitsumoto

  • Abstract
  • Full Text
  • Full Text (PDF)